European Regulation of Medical Devices and Pharmaceuticals: Regulatee Expectations of Legal Certainty - Image 1

£89.99

Springer European Regulation of Medical Devices and Pharmaceuticals: Regulatee Expectations of Legal Certainty

Name: European Regulation of Medical Devices and Pharmaceuticals: Regulatee Expectations of Legal Certainty
Brand: Springer
Price: 89.99 GBP
Availability: InStock

International

This is the most expensive it has ever been. Walk away.

£90 today · previous high £90 · all-time low £75

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 8 days • 8 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 8 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £75 (7 days, 87.5%)

Price range: £75 - £90

Price levels: 2 different prices over 8 days

Description

One of the primary functions of law is to ensure that the legal structure governing all social relations is predictable, coherent, consistent and applicable. Taken together, these characteristics of law are referred to as legal certainty. In traditional approaches to legal certainty, law is regarded as a hierarchical system of rules characterized by stability, clarity, uniformity, calculable enforcement, publicity and predictability. However, the current reality is that national legal systems no longer operate in isolation, but within a multilevel legal order, wherein norms created at both the international and regional level are directly applicable to national legal systems. Also, norm creation is no longer the exclusive prerogative of public officials of the state: private actors have an increasing influence on norm creation as well. Social scientists have referred to this phenomenon of interacting and overlapping competences as multilevel governance. Only recently have legal scholars focused attention on the increasing interconnectedness (and therefore the concomitant loss of primacy of national legal orders) between the global, European and national regulatory spheres through the concept of multilevel regulation. In this project the author uses multilevel regulation as a term to characterize a regulatory space in which the process of rule making, rule enforcement and rule adjudication (the regulatory lifecycle) is dispersed across more than one administrative or territorial level and amongst several different actors, both public and private. The author draws on the concept of a regulatory space, using it as a framing device to differentiate between specific aspects of policy fields. The relationship between actors in such a space is non-hierarchical and they may be independent of each other. The lack of central ordering of the regulatory lifecycle within this regulatory space is the most important feature of such a space. The implications of multilevel regulation for the notion of legal certainty have attracted limited attention from scholars and the demand for legal certainty in regulatory practice is still a puzzle. The book explores the idea of legal certainty in terms of the perceptions and expectations of regulatees in the context of medical products – specifically, pharmaceuticals and medical devices, which can be differentiated as two regulatory spaces and therefore form two case studies. As an exploratory project, the book necessarily explores new territory in terms of investigating legal certainty first in terms of regulatee perceptions and expectations and second, because it studies it in the context of multilevel regulation.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 3319045938
Category: Books > Subjects > Business, Finance & Law > Accounting > International
Domain: Amazon UK
Release Date: 15 May 2014
Listed Since: 26 December 2013

Barcode

No barcode data available

Springer European Regulation of Medical Devices and Pharmaceuticals: Regulatee Expectations of Legal Certainty

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

The Regulation of Medical Products: Dope, Drugs and Devices (Law, Science and Society)

Medical Product Regulatory Affairs: Pharmaceuticals, Diagnostics, Medical Devices

Guide to EU and UK Pharmaceutical Regulatory Law

Blankettstrafgesetze und ihre verfassungsrechtlichen Grenzen: 1 (Juridicum - Schriften zum Wirtschaftsstrafrecht, 1)

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

Das europäische Arzneimittelrecht: Zentrale Rechtsfragen des Arzneimittelzulassungsverfahrens

Guide to EU Pharmaceutical Regulatory Law

Medical Product Regulatory Affairs: Pharmaceuticals, Diagnostics, Medical Devices

Drug Control and International Law (Routledge Research in International Law)

Neoliberalism, State-Corporate Power and Regulatory Failure: The Harms of Prescription and Non-Prescription Medicine Regulation in Australia (Routledge Studies in Crime and Society)

Targeted Regulatory Writing Techniques: Clinical Documents for Drugs and Biologics

Medicines, Medical Devices and the Law

Medicines, Medical Devices and the Law

Legal Medicine 1985

Computer System Validation: Pharmaceutical, Biologics, and Medical Device Regulations, Concise Reference

The Law of Off-label Uses of Medicines: Regulation and Litigation in the EU, UK and USA

European Law and New Health Technologies (Oxford Studies in European Law)

Counterfeit and Falsified Medicines in the EU: A Legal Perspective (Elgar Studies in Health and the Law)

Practical Guide to 21 CFR Part 11: Your Essential Handbook for Navigating 21 CFR Part 11

Practical Guide to 21 CFR Part 11: Your Essential Handbook for Navigating 21 CFR Part 11

Artificial Intelligence in Drug Development: Patenting and Regulatory Aspects (Frontiers of Artificial Intelligence, Ethics and Multidisciplinary Applications)

Write It Down: Guidance for Preparing Effective and Compliant Documentation

Write It Down: Guidance for Preparing Effective and Compliant Documentation

The 2023 Report on Pharma Contract Sales: World Market Segmentation by City